https://news.medxy.ai/zh/%e7%bb%93%e5%a4%96nk-t%e7%bb%86%e8%83%9e%e6%b7%8b%e5%b7%b4%e7%98%a4%e5%8f%8c%e9%87%8d%e8%80%90%e8%8d%af%e5%9b%b0%e5%b1%80%ef%bc%9a%e6%8c%91%e6%88%98%e4%b8%8e%e6%96%b0%e5%90%af%e7%a4%ba/Medxy AIzh2026-07-15T13:38:55-07:00结外NK/T细胞淋巴瘤双重耐药困局：挑战与新启示 https://news.medxy.ai/ja/%e7%af%80%e5%a4%96%e6%80%a7nk-t%e7%b4%b0%e8%83%9e%e3%83%aa%e3%83%b3%e3%83%91%e8%85%ab%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e4%ba%8c%e9%87%8d%e8%80%90%e6%80%a7%e3%82%92%e3%81%a9%e3%81%86%e5%85%8b/Medxy AIja2026-07-15T13:38:32-07:00節外性NK/T細胞リンパ腫における二重耐性をどう克服するか：課題と新たな知見 https://news.medxy.ai/vi/khang-kep-trong-lymphoma-te-bao-nk-t-ngoai-hach-thach-thuc-dieu-tri-va-nhung-tin-hieu-moi-day-hua-hen/Medxy AIvi2026-07-15T13:38:08-07:00Kháng kép trong lymphoma tế bào NK/T ngoài hạch: Thách thức điều trị và những tín hiệu mới đầy hứa hẹn https://news.medxy.ai/navigating-dual-resistance-in-extranodal-nk-t-cell-lymphoma-challenges-and-emerging-insights/Medxy AIen2026-07-15T13:37:23-07:00Navigating Dual Resistance in Extranodal NK/T-Cell Lymphoma: Challenges and Emerging Insights https://news.medxy.ai/zh/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia-3/Medxy AIzh2026-07-15T13:33:53-07:00分子突变与心血管风险共同决定三阴性原发性血小板增多症的预后 https://news.medxy.ai/ja/molecular-mutations-and-cardiovascular-risks-impact-prognosis-in-triple-negative-essential-thrombocythemia/Medxy AIja2026-07-15T13:33:31-07:00三重陰性本態性血小板血症の予後を左右する分子変異と心血管リスク https://news.medxy.ai/vi/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia-2/Medxy AIvi2026-07-15T13:33:05-07:00Đột biến phân tử và nguy cơ tim mạch định hình tiên lượng trong tăng tiểu cầu tiên phát âm tính ba đột biến https://news.medxy.ai/molecular-mutations-and-cardiovascular-risks-shape-prognosis-in-triple-negative-essential-thrombocythemia/Medxy AIen2026-07-15T13:32:13-07:00Molecular Mutations and Cardiovascular Risks Shape Prognosis in Triple-Negative Essential Thrombocythemia https://news.medxy.ai/vi/flt3-itd-signaling-drives-immune-evasion-via-pkc-stat1/Medxy AIvi2026-07-15T11:29:43-07:00Tín hiệu FLT3-ITD phi kinh điển thúc đẩy né tránh miễn dịch qua kiệt sức tế bào T CD8+ do trục PKCι–STAT1 trung gian trong bệnh bạch cầu tủy cấp https://news.medxy.ai/flt3-itd-signaling-drives-immune-evasion/Medxy AIen2026-07-15T11:28:49-07:00Noncanonical FLT3-ITD Signaling Drives Immune Evasion via PKCι-STAT1–Mediated CD8+ T-Cell Exhaustion in Acute Myeloid Leukemia https://news.medxy.ai/harnessing-precision-medicine-the-aps-consortiums-national-platform-for-phenotyping-ards-pneumonia-and-sepsis/Medxy AIen2026-07-15T11:11:44-07:00Harnessing Precision Medicine: The APS Consortium’s National Platform for Phenotyping ARDS, Pneumonia, and Sepsis https://news.medxy.ai/zh/loss-of-y-chromosome-to-pulmonary-decline-and-epigenetic-aging-in-men/Medxy AIzh2026-07-15T11:06:12-07:00Y染色体嵌合性丢失与男性肺功能减退、肺气肿及表观遗传衰老加速相关：综合综述 https://news.medxy.ai/ja/loss-of-y-chromosome-links-to-pulmonary-decline-and-epigenetic-aging-in-men/Medxy AIja2026-07-15T11:05:46-07:00Y染色体モザイク喪失は男性の肺機能低下・肺気腫・エピジェネティック老化加速と関連する：包括的レビュー https://news.medxy.ai/vi/mosaic-loss-of-y-chromosome-links-to-pulmonary-decline-emphysema-and-accelerated-epigenetic-aging-in-men/Medxy AIvi2026-07-15T11:05:18-07:00Mất nhiễm sắc thể Y dạng khảm liên quan đến suy giảm chức năng phổi, khí phế thũng và lão hóa biểu sinh tăng tốc ở nam giới: Tổng quan toàn diện https://news.medxy.ai/mosaic-loss-of-y-chromosome-links-to-pulmonary-decline-emphysema-and-accelerated-epigenetic-aging-in-men-a-comprehensive-review/Medxy AIen2026-07-15T11:04:15-07:00Mosaic Loss of Y Chromosome Links to Pulmonary Decline, Emphysema, and Accelerated Epigenetic Aging in Men: A Comprehensive Review https://news.medxy.ai/zh/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-for-diabetic-retinopathy-risk/Medxy AIzh2026-07-15T10:59:31-07:00面扫OCT揭示中层视网膜高反射异常区：糖尿病视网膜病变风险分层的新型生物标志物 https://news.medxy.ai/ja/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-for-diabetic-retinopathy-risk-stratification/Medxy AIja2026-07-15T10:59:11-07:00en face OCTで捉える中網膜層の高反射異常：糖尿病網膜症リスク層別化の新規バイオマーカー https://news.medxy.ai/vi/hyperreflective-abnormal-areas-in-middle-retinal-layers/Medxy AIvi2026-07-15T10:58:49-07:00Vùng bất thường tăng phản xạ ở lớp giữa võng mạc trên en face OCT: Biomarker mới cho phân tầng nguy cơ bệnh võng mạc đái tháo đường https://news.medxy.ai/hyperreflective-abnormal-areas-in-middle-retinal-layers-via-en-face-oct-a-novel-biomarker-for-diabetic-retinopathy-risk-stratification/Medxy AIen2026-07-15T10:51:47-07:00Hyperreflective Abnormal Areas in Middle Retinal Layers via En Face OCT: A Novel Biomarker for Diabetic Retinopathy Risk Stratification https://news.medxy.ai/artificial-intelligence-smart-eyeglasses-for-the-detection-and-description-of-stationary-objects-a-pilot-feasibility-study/Medxy AIen2026-07-15T10:37:49-07:00Artificial Intelligence Smart Eyeglasses for the Detection and Description of Stationary Objects: A Pilot Feasibility Study https://news.medxy.ai/ja/a-consensus-for-ai-screening-of-age-related-macular-degeneration/Medxy AIja2026-07-15T10:37:18-07:00AMDスクリーニングAIの参照標準をどう定めるか：臨床医と開発者が知っておくべき要点 https://news.medxy.ai/vi/a-consensus-standard-for-ai-screening-of-age-related-macular-degeneration/Medxy AIvi2026-07-15T10:36:31-07:00Chuẩn tham chiếu đồng thuận cho sàng lọc AMD bằng AI: Bác sĩ lâm sàng và nhà phát triển cần biết gì https://news.medxy.ai/zh/a-consensus-reference-standard-for-ai-screening-of-age-related-macular-degeneration/Medxy AIzh2026-07-15T10:35:44-07:00AMD筛查AI的共识参考标准：临床与开发者必须了解什么 https://news.medxy.ai/a-consensus-reference-standard-for-ai-screening-of-age-related-macular-degeneration-what-clinicians-and-developers-need-to-know/Medxy AIen2026-07-15T10:33:52-07:00A Consensus Reference Standard for AI Screening of Age-Related Macular Degeneration: What Clinicians and Developers Need to Know https://news.medxy.ai/vi/bridging-subjective-symptoms-and-objective-imaging-in-chronic-rhinosinusitis/Medxy AIvi2026-07-15T10:28:30-07:00Kết nối triệu chứng chủ quan với hình ảnh học khách quan trong viêm mũi xoang mạn tính: tác động của Sino-Nasal Outcome Test thích ứng https://news.medxy.ai/bridging-subjective-symptoms-and-objective-imaging-in-chronic-rhinosinusitis-impact-of-an-adaptive-sino-nasal-outcome-test/Medxy AIen2026-07-15T10:27:39-07:00Bridging Subjective Symptoms and Objective Imaging in Chronic Rhinosinusitis: Impact of an Adaptive Sino-Nasal Outcome Test https://news.medxy.ai/ja/recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis/Medxy AIja2026-07-15T10:20:01-07:00小児片側声帯麻痺に対する後咽頭神経再神経支配の有効性：単一施設最大規模シリーズからの知見 https://news.medxy.ai/vi/efficacy-of-recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis/Medxy AIvi2026-07-15T10:19:36-07:00Tái phân bố thần kinh dây thần kinh thanh quản quặt ngược trong liệt dây thanh âm một bên ở trẻ em: kinh nghiệm từ loạt ca đơn trung tâm lớn nhất https://news.medxy.ai/efficacy-of-recurrent-laryngeal-nerve-reinnervation-in-pediatric-unilateral-vocal-fold-paralysis-insights-from-a-largest-single-center-series/Medxy AIen2026-07-15T10:18:08-07:00Efficacy of Recurrent Laryngeal Nerve Reinnervation in Pediatric Unilateral Vocal Fold Paralysis: Insights from a Largest Single-Center Series https://news.medxy.ai/zh/outcomes-of-colorectal-dysplasia-and-cancer-in-psc-ibd-liver-transplantation-and-colectomy/Medxy AIzh2026-07-15T10:16:25-07:00PSC-IBD患者行肝移植与结肠切除的结直肠异型增生和癌症结局：一项多中心研究 https://news.medxy.ai/ja/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd/Medxy AIja2026-07-15T10:16:01-07:00PSC-IBD合併患者における大腸異形成・大腸癌の転帰：肝移植と結腸切除の順序を検討した多施設研究 https://news.medxy.ai/vi/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy/Medxy AIvi2026-07-15T10:15:34-07:00Kết cục loạn sản và ung thư đại trực tràng ở bệnh nhân PSC-IBD sau ghép gan và cắt đại tràng: Góc nhìn từ một nghiên cứu đa trung tâm https://news.medxy.ai/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy-insights-from-a-multicenter-study/Medxy AIen2026-07-15T10:14:41-07:00Outcomes of Colorectal Dysplasia and Cancer in Patients with PSC-IBD Undergoing Liver Transplantation and Colectomy: Insights from a Multicenter Study https://news.medxy.ai/zh/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-pet-ct-imaging/Medxy AIzh2026-07-15T10:11:15-07:00标本 PET-CT 助力早期乳腺癌术中切缘评估：BrIMA 试验带来的新启示 https://news.medxy.ai/ja/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging/Medxy AIja2026-07-15T10:10:49-07:00標本PET-CTで早期乳がんの術中断端評価を高度化：BrIMA試験の知見 https://news.medxy.ai/vi/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging/Medxy AIvi2026-07-15T10:10:18-07:00PET-CT trên bệnh phẩm giúp nâng cao đánh giá diện cắt trong mổ ở ung thư vú giai đoạn sớm: Góc nhìn từ thử nghiệm BrIMA https://news.medxy.ai/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging-insights-from-the-brima-trial/Medxy AIen2026-07-15T10:08:56-07:00Enhancing Intraoperative Margin Assessment in Early-Stage Breast Cancer with Specimen PET-CT Imaging: Insights from the BrIMA Trial https://news.medxy.ai/zh/endobarrier-duodenal-jejunal-bypass-liner-for-glycemic-control-and-weight-loss-in-t2dm/Medxy AIzh2026-07-15T10:08:39-07:00EndoBarrier十二指肠-空肠旁路衬套：一种用于改善2型糖尿病合并肥胖患者血糖控制与减重的创新性内镜辅助治疗 https://news.medxy.ai/ja/endobarrier-duodenal-jejunal-bypass-liner-for-improved-glycemic-control-and-weight-loss-in-t2dm/Medxy AIja2026-07-15T10:08:16-07:00EndoBarrier十二指腸‐空腸バイパスライナー：肥満を伴う2型糖尿病に対する血糖改善・減量を目指す新しい内視鏡補助療法 https://news.medxy.ai/vi/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-t2dm/Medxy AIvi2026-07-15T10:07:47-07:00EndoBarrier duodenal-jejunal bypass liner: Thiết bị nội soi mới giúp cải thiện kiểm soát đường huyết và giảm cân ở đái tháo đường type 2 kèm béo phì https://news.medxy.ai/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-type-2-diabetes-with-obesity/Medxy AIen2026-07-15T10:06:44-07:00EndoBarrier Duodenal-Jejunal Bypass Liner: A Novel Endoscopic Adjunct for Improved Glycemic Control and Weight Loss in Type 2 Diabetes with Obesity https://news.medxy.ai/zh/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma-2/Medxy AIzh2026-07-15T10:00:03-07:00借助HRD检测与MYC扩增优化BRCA野生型高级别浆液性卵巢癌中的PARP抑制剂应用 https://news.medxy.ai/ja/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma/Medxy AIja2026-07-15T09:59:42-07:00BRCA野生型高異型度漿液性卵巣癌におけるPARP阻害薬最適化のためのHRD検査とMYC増幅の活用 https://news.medxy.ai/vi/harnessing-hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma/Medxy AIvi2026-07-15T09:59:21-07:00Khai thác xét nghiệm HRD và khuếch đại MYC để tối ưu hóa sử dụng chất ức chế PARP trong ung thư biểu mô thanh dịch độ cao buồng trứng BRCA hoang dại https://news.medxy.ai/harnessing-hrd-testing-and-myc-amplification-to-optimize-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma/Medxy AIen2026-07-15T09:58:18-07:00Harnessing HRD Testing and MYC Amplification to Optimize PARP Inhibitor Use in BRCA Wild-Type High-Grade Serous Ovarian Carcinoma https://news.medxy.ai/zh/severe-lead-poisoning-during-pregnancy/Medxy AIzh2026-07-15T09:29:19-07:00妊娠期重度铅中毒：纽约市19年观察性研究带来的启示 https://news.medxy.ai/ja/severe-lead-poisoning-during-pregnancy-from-a-19-year-study/Medxy AIja2026-07-15T09:29:04-07:00妊娠中の重度鉛中毒：19年間のNYC観察研究から得られた知見 https://news.medxy.ai/vi/severe-lead-poisoning-during-pregnancy-from-a-19-year-observational-study/Medxy AIvi2026-07-15T09:28:42-07:00Ngộ độc chì nặng trong thai kỳ: Những phát hiện từ nghiên cứu quan sát 19 năm tại Thành phố New York https://news.medxy.ai/severe-lead-poisoning-during-pregnancy-insights-from-a-19-year-nyc-observational-study/Medxy AIen2026-07-15T09:27:18-07:00Severe Lead Poisoning During Pregnancy: Insights from a 19-Year NYC Observational Study https://news.medxy.ai/zh/fibroblast-diversity-in-vaginal-wall-prolapse-from-single-nucleus-transcriptomics/Medxy AIzh2026-07-15T09:25:37-07:00阴道壁脱垂中成纤维细胞多样性的解析：来自单核转录组学的启示 https://news.medxy.ai/ja/fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics/Medxy AIja2026-07-15T09:25:21-07:00単一核トランスクリプトミクスで解く、膣壁脱出における線維芽細胞の多様性 https://news.medxy.ai/vi/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse/Medxy AIvi2026-07-15T09:25:02-07:00Khám phá sự đa dạng của nguyên bào sợi trong sa thành âm đạo: góc nhìn từ transcriptomics đơn nhân https://news.medxy.ai/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics/Medxy AIen2026-07-15T09:24:01-07:00Unraveling Fibroblast Diversity in Vaginal Wall Prolapse: Insights from Single-Nucleus Transcriptomics https://news.medxy.ai/zh/reclassifying-pediatric-nafld-by-the-steatotic-liver-disease-framework/Medxy AIzh2026-07-15T09:12:29-07:00儿童 NAFLD 重新分类：来自多中心 NASH CRN 研究的脂肪性肝病框架新见解 https://news.medxy.ai/ja/reclassifying-pediatric-nafld-from-the-steatotic-liver-disease-framework/Medxy AIja2026-07-15T09:12:10-07:00小児NAFLDを再考する：多施設NASH CRN研究が示す脂肪性肝疾患枠組みの意義 https://news.medxy.ai/vi/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework/Medxy AIvi2026-07-15T09:11:43-07:00Phân loại lại NAFLD ở trẻ em: Góc nhìn từ khung bệnh gan nhiễm mỡ trong nghiên cứu đa trung tâm NASH CRN https://news.medxy.ai/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework-in-a-multicenter-nash-crn-study/Medxy AIen2026-07-15T09:10:23-07:00Reclassifying Pediatric NAFLD: Insights from the Steatotic Liver Disease Framework in a Multicenter NASH CRN Study https://news.medxy.ai/ja/longterm-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen/Medxy AIja2026-07-14T22:53:42-07:00HBsAg消失後の肝細胞癌リスク：長期追跡で見えた年齢と肝硬変の影響 https://news.medxy.ai/vi/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen/Medxy AIvi2026-07-14T22:53:25-07:00Nguy cơ dài hạn ung thư biểu mô tế bào gan sau khi HBsAg được thanh thải https://news.medxy.ai/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hepatitis-b-surface-antigen/Medxy AIen2026-07-14T22:52:42-07:00Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen https://news.medxy.ai/vi/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions-2/Medxy AIvi2026-07-14T18:09:38-07:00MAD-MT: Công cụ mới giúp chọn đúng bệnh nhân cho lấy huyết khối cơ học ở tắc mạch não xa https://news.medxy.ai/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions/Medxy AIen2026-07-14T18:08:23-07:00MAD-MT Score: Enhancing Patient Selection for Mechanical Thrombectomy in Distal Vessel Occlusions https://news.medxy.ai/zh/prion-diseases-from-alzheimers-disease-by-plasma-nfl-p-tau217-ratio/Medxy AIzh2026-07-14T18:05:03-07:00用血浆生物标志物区分朊蛋白病与阿尔茨海默病：NfL/p-tau217 比值的关键作用 https://news.medxy.ai/ja/prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio/Medxy AIja2026-07-14T18:04:43-07:00血漿バイオマーカーでプリオン病とアルツハイマー病を見分ける：NfL/p-tau217比の決定的役割 https://news.medxy.ai/vi/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio/Medxy AIvi2026-07-14T18:04:15-07:00Phân biệt bệnh prion với bệnh Alzheimer bằng dấu ấn sinh học huyết tương: vai trò then chốt của tỷ lệ NfL/p-tau217 https://news.medxy.ai/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-biomarkers-the-crucial-role-of-nfl-p-tau217-ratio/Medxy AIen2026-07-14T18:03:13-07:00Discriminating Prion Diseases from Alzheimer’s Disease Using Plasma Biomarkers: The Crucial Role of NfL/p-tau217 Ratio https://news.medxy.ai/zh/acute-neural-biomarker-elevations-after-amateur-soccer-heading-into-potential-brain-injury/Medxy AIzh2026-07-14T18:01:43-07:00业余足球头球后急性神经生物标志物升高：脑损伤风险的新线索 https://news.medxy.ai/ja/acute-neural-biomarker-after-amateur-soccer-heading/Medxy AIja2026-07-14T18:01:20-07:00アマチュアサッカーのヘディング後にみられる急性神経バイオマーカー上昇：脳障害リスクを考える https://news.medxy.ai/vi/acute-neural-biomarker-elevations-after-amateur-soccer-heading/Medxy AIvi2026-07-14T18:00:53-07:00Đánh đầu trong bóng đá nghiệp dư làm tăng cấp tính các dấu ấn sinh học thần kinh: gợi ý về nguy cơ tổn thương não https://news.medxy.ai/acute-neural-biomarker-elevations-after-amateur-soccer-heading-insights-into-potential-brain-injury/Medxy AIen2026-07-14T18:00:02-07:00Acute Neural Biomarker Elevations After Amateur Soccer Heading: Insights Into Potential Brain Injury https://news.medxy.ai/zh/immune-subtypes-in-t1dm/Medxy AIzh2026-07-14T17:57:19-07:001型糖尿病的免疫学分型新发现：解析疾病进展与个体化免疫治疗 https://news.medxy.ai/ja/immune-subtypes-in-type-1-diabetes/Medxy AIja2026-07-14T17:57:00-07:001型糖尿病における免疫サブタイプの違い：病勢進行と個別化免疫療法への示唆 https://news.medxy.ai/vi/immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy/Medxy AIvi2026-07-14T17:56:40-07:00Đái tháo đường type 1 không đồng nhất về miễn dịch: ý nghĩa đối với tiến triển bệnh và miễn dịch trị liệu cá thể hóa https://news.medxy.ai/distinct-immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy/Medxy AIen2026-07-14T17:55:44-07:00Distinct Immune Subtypes in Type 1 Diabetes: Implications for Disease Progression and Personalized Immunotherapy https://news.medxy.ai/zh/next-generation-pharmacotherapies-in-obesity-transforming-care/Medxy AIzh2026-07-14T15:09:54-07:00肥胖治疗新纪元：精准干预与多系统获益的下一代药物 https://news.medxy.ai/ja/pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits/Medxy AIja2026-07-14T15:09:34-07:00肥満治療の新時代：精密医療と多面的ベネフィットをもたらす次世代薬物療法 https://news.medxy.ai/vi/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits-2/Medxy AIvi2026-07-14T15:09:11-07:00Liệu pháp điều trị béo phì thế hệ mới: Chuyển đổi chăm sóc nhờ y học chính xác và lợi ích đa hệ thống https://news.medxy.ai/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits/Medxy AIen2026-07-14T15:08:16-07:00Next-Generation Pharmacotherapies in Obesity: Transforming Care with Precision and Multisystem Benefits https://news.medxy.ai/vi/low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide/Medxy AIvi2026-07-14T15:07:44-07:00ATG liều thấp trong đái tháo đường type 1: Góc nhìn thực tế qua đáp ứng định lượng hiệu chỉnh của C-peptide https://news.medxy.ai/exploring-low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide/Medxy AIen2026-07-14T15:07:05-07:00Exploring Low-Dose Antithymocyte Globulin Therapy in Type 1 Diabetes: Real-World Insights Using Modified Quantitative Response of C-Peptide https://news.medxy.ai/vi/early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine/Medxy AIvi2026-07-14T15:04:15-07:00HERZCHECK: Mở ra hướng phát hiện sớm suy tim tiền lâm sàng ở nông thôn bằng MRI tim di động và y tế từ xa https://news.medxy.ai/herzcheck-revolutionizing-early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine/Medxy AIen2026-07-14T15:03:30-07:00HERZCHECK: Revolutionizing Early Detection of Subclinical Preheart Failure in Rural Regions via Mobile Cardiac MRI and Telemedicine https://news.medxy.ai/zh/maternal-diabetes-increase-the-risk-of-early-onset-cardiovascular-disease-in-offspring/Medxy AIzh2026-07-14T14:37:22-07:00母体糖尿病与子代早发心血管疾病风险升高：来自瑞典全国队列研究的启示 https://news.medxy.ai/ja/maternal-diabetes-and-the-risk-of-early-onset-cardiovascular-disease-in-offspring/Medxy AIja2026-07-14T14:37:06-07:00母体糖尿病は子どもの早発心血管疾患リスクを高める：スウェーデン全国コホート研究からの知見 https://news.medxy.ai/vi/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring/Medxy AIvi2026-07-14T14:36:47-07:00Đái tháo đường của mẹ và nguy cơ bệnh tim mạch khởi phát sớm ở con: bằng chứng từ một nghiên cứu đoàn hệ toàn quốc tại Thụy Điển https://news.medxy.ai/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring-insights-from-a-swedish-nationwide-cohort-study/Medxy AIen2026-07-14T14:36:06-07:00Maternal Diabetes and the Elevated Risk of Early-Onset Cardiovascular Disease in Offspring: Insights from a Swedish Nationwide Cohort Study https://news.medxy.ai/ja/wine-consumption-mediterranean-diet-and-cardiovascular-disease/Medxy AIja2026-07-14T14:08:02-07:00地中海食とワイン摂取は心血管リスクにどう関わるか――スペイン2コホート研究 https://news.medxy.ai/vi/wine-consumption-mediterranean-diet-and-cardiovascular-risk/Medxy AIvi2026-07-14T14:07:44-07:00Rượu vang, chế độ ăn Địa Trung Hải và nguy cơ tim mạch: bằng chứng từ hai đoàn hệ Tây Ban Nha https://news.medxy.ai/wine-consumption-mediterranean-diet-and-cardiovascular-risk-in-two-spanish-cohorts/Medxy AIen2026-07-14T14:07:10-07:00Wine Consumption, Mediterranean Diet, and Cardiovascular Risk in Two Spanish Cohorts https://news.medxy.ai/zh/orbita-cto-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina/Medxy AIzh2026-07-14T14:03:44-07:00ORBITA-CTO试验：评估经皮冠状动脉介入治疗对稳定型心绞痛症状性慢性完全闭塞的影响 https://news.medxy.ai/ja/orbita-cto%e8%a9%a6%e9%a8%93%ef%bc%9a%e5%ae%89%e5%ae%9a%e7%8b%ad%e5%bf%83%e7%97%87%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e7%97%87%e5%80%99%e6%80%a7%e6%85%a2%e6%80%a7%e5%ae%8c%e5%85%a8%e9%96%89%e5%a1%9e/Medxy AIja2026-07-14T14:03:20-07:00ORBITA-CTO試験：安定狭心症における症候性慢性完全閉塞への経皮的冠動脈インターベンションの影響を検証 https://news.medxy.ai/vi/orbita-cto-trial-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina/Medxy AIvi2026-07-14T14:03:00-07:00ORBITA-CTO: Đánh giá tác động của can thiệp mạch vành qua da lên tắc nghẽn mạn tính hoàn toàn có triệu chứng trong đau thắt ngực ổn định https://news.medxy.ai/orbita-cto-trial-evaluating-the-impact-of-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina/Medxy AIen2026-07-14T14:02:19-07:00ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina https://news.medxy.ai/vi/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis/Medxy AIvi2026-07-14T13:47:52-07:00Phơi nhiễm vi nhựa và bệnh cơ tim: Hé lộ cơ chế trục ruột-tim https://news.medxy.ai/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis-mechanism/Medxy AIen2026-07-14T13:47:08-07:00Microplastic Exposure and Cardiomyopathy: Unveiling the Gut-Heart Axis Mechanism https://news.medxy.ai/zh/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-es-sclc/Medxy AIzh2026-07-14T11:33:00-07:00广泛期小细胞肺癌中巩固性胸部放疗联合阿替利珠单抗维持：TREASURE 2期试验带来的启示 https://news.medxy.ai/ja/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-sclc/Medxy AIja2026-07-14T11:32:41-07:00進展型小細胞肺癌に対するアテゾリズマブ維持療法への胸部集学的放射線療法追加を検証：第2相TREASURE試験の知見 https://news.medxy.ai/vi/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer/Medxy AIvi2026-07-14T11:32:19-07:00Xạ trị lồng ngực củng cố kết hợp duy trì atezolizumab trong ung thư phổi tế bào nhỏ giai đoạn lan rộng: Kết quả nổi bật từ thử nghiệm TREASURE pha 2 https://news.medxy.ai/evaluating-consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer/Medxy AIen2026-07-14T11:31:23-07:00Evaluating Consolidative Thoracic Radiotherapy with Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: Insights from the Phase 2 TREASURE Trial https://news.medxy.ai/zh/ctdna-outperforms-for-monitoring-recurrence-in-merkel-cell-carcinoma/Medxy AIzh2026-07-14T10:58:06-07:00ctDNA在Merkel细胞癌复发监测中优于MCPyV抗体检测 https://news.medxy.ai/ja/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-recurrence-in-merkel-cell-carcinoma/Medxy AIja2026-07-14T10:57:50-07:00メルケル細胞癌の再発監視ではctDNAがMCPyV抗体を上回る https://news.medxy.ai/vi/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma/Medxy AIvi2026-07-14T10:57:31-07:00ctDNA vượt trội hơn kháng thể MCPyV trong theo dõi tái phát ung thư biểu mô tế bào Merkel https://news.medxy.ai/circulating-tumor-dna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma/Medxy AIen2026-07-14T10:56:44-07:00Circulating Tumor DNA Outperforms Merkel Cell Polyomavirus Antibodies for Monitoring Recurrence in Merkel Cell Carcinoma https://news.medxy.ai/zh/institutional-and-insurance-linked-disparities-in-melanoma-outcomes/Medxy AIzh2026-07-14T10:38:23-07:00黑色素瘤结局中的机构与保险差异：来自 VA 中心与三级医疗中心队列研究的启示 https://news.medxy.ai/ja/institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study/Medxy AIja2026-07-14T10:38:01-07:00メラノーマ転帰の施設差・保険差を探る：VAセンターと三次医療コホートからの知見 https://news.medxy.ai/vi/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes/Medxy AIvi2026-07-14T10:37:40-07:00U hắc tố: khác biệt về kết cục giữa cơ sở điều trị và bảo hiểm trong một nghiên cứu đoàn hệ từ VA và trung tâm chăm sóc bậc ba https://news.medxy.ai/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study/Medxy AIen2026-07-14T10:36:47-07:00Exploring Institutional and Insurance-Linked Disparities in Melanoma Outcomes: Insights from a VA and Tertiary Care Cohort Study https://news.medxy.ai/zh/misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes/Medxy AIzh2026-07-14T10:23:18-07:00破除误区：如何应对患者对透明质酸填充剂的认知偏差，以实现理想审美效果 https://news.medxy.ai/ja/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-aesthetic-outcomes/Medxy AIja2026-07-14T10:22:59-07:00ヒアルロン酸フィラーの誤解を解く：自然な仕上がりをかなえる患者対応の要点 https://news.medxy.ai/vi/navigating-patient-misconceptions-about-hyaluronic-acid-for-optimal-aesthetic-outcomes/Medxy AIvi2026-07-14T10:22:34-07:00Xóa bỏ hiểu lầm: Hiểu đúng quan niệm của bệnh nhân về chất làm đầy acid hyaluronic để tối ưu kết quả thẩm mỹ https://news.medxy.ai/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes/Medxy AIen2026-07-14T10:21:43-07:00Dispelling Myths: Navigating Patient Misconceptions About Hyaluronic Acid Fillers for Optimal Aesthetic Outcomes https://news.medxy.ai/zh/facial-reanimation-outcomes-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures/Medxy AIzh2026-07-14T10:17:32-07:00提升面部复苏效果：三重神经移位术中联合阔筋膜张肌筋膜悬吊的价值 https://news.medxy.ai/ja/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer/Medxy AIja2026-07-14T10:17:13-07:00顔面再活性化の成績を高める：Triple nerve transfer における fascia lata suspension の有用性 https://news.medxy.ai/vi/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures/Medxy AIvi2026-07-14T10:16:46-07:00Cải thiện kết quả hồi sinh khuôn mặt: Vai trò của treo cân đùi trong chuyển ghép ba dây thần kinh https://news.medxy.ai/enhancing-facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures/Medxy AIen2026-07-14T10:15:37-07:00Enhancing Facial Reanimation Outcomes: The Impact of Fascia Lata Suspension in Triple Nerve Transfer Procedures https://news.medxy.ai/zh/the-economic-impact-of-enhanced-primary-youth-mental-health-services/Medxy AIzh2026-07-14T10:09:58-07:00强化青少年初级精神卫生服务的经济价值：来自 ACCESS Open Minds 研究的启示 https://news.medxy.ai/ja/enhanced-primary-youth-mental-health-services/Medxy AIja2026-07-14T10:09:38-07:00強化された若年精神保健の経済効果を検証する：ACCESS Open Minds 研究から見える成果 https://news.medxy.ai/vi/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services/Medxy AIvi2026-07-14T10:09:18-07:00Đánh giá tác động kinh tế của các dịch vụ sức khỏe tâm thần ban đầu tăng cường cho thanh thiếu niên: Góc nhìn từ nghiên cứu ACCESS Open Minds https://news.medxy.ai/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services-insights-from-the-access-open-minds-study/Medxy AIen2026-07-14T10:07:54-07:00Evaluating the Economic Impact of Enhanced Primary Youth Mental Health Services: Insights from the ACCESS Open Minds Study https://news.medxy.ai/vi/effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder/Medxy AIvi2026-07-14T09:34:38-07:00DBT hay ST: Hiệu quả điều trị nào tốt hơn cho rối loạn nhân cách ranh giới? Kết quả từ thử nghiệm BOOTS https://news.medxy.ai/comparative-effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder/Medxy AIen2026-07-14T09:33:28-07:00Comparative Effectiveness of Dialectical Behavior Therapy and Schema Therapy in Borderline Personality Disorder: Insights from the BOOTS Trial https://news.medxy.ai/zh/sex-differences-in-critical-care-outcomes-3/Medxy AIzh2026-07-14T09:29:41-07:00印度最大ICU注册研究揭示：重症结局存在性别差异吗？ https://news.medxy.ai/ja/sex-differences-in-critical-care-outcomes-2/Medxy AIja2026-07-14T09:29:21-07:00ICU転帰にみる性差：インド最大級レジストリが示した知見 https://news.medxy.ai/vi/sex-differences-in-critical-care-outcomes-in-india/Medxy AIvi2026-07-14T09:29:02-07:00Khác biệt giới trong kết cục hồi sức tích cực: Những phát hiện từ cơ sở đăng ký ICU lớn nhất của Ấn Độ https://news.medxy.ai/sex-differences-in-critical-care-outcomes/Medxy AIen2026-07-14T09:27:33-07:00Sex Differences in Critical Care Outcomes: Insights from India’s Largest ICU Registry https://news.medxy.ai/zh/suicide-prevention-of-teen-and-caregiver-in-the-emergency-department/Medxy AIzh2026-07-14T09:21:22-07:00提升自杀预防：急诊科中青少年与照护者对致命手段安全规划的看法 https://news.medxy.ai/ja/enhancing-suicide-prevention-of-teen-and-caregiver-in-the-emergency-department/Medxy AIja2026-07-14T09:21:07-07:00救急外来における自殺予防を強化する：致死手段安全性計画をめぐるティーンと養育者の視点 https://news.medxy.ai/vi/enhancing-suicide-prevention-teen-and-caregiver-in-the-emergency-department/Medxy AIvi2026-07-14T09:20:47-07:00Tăng cường phòng ngừa tự sát: Góc nhìn của thanh thiếu niên và người chăm sóc về lập kế hoạch an toàn với phương tiện gây tử vong tại khoa cấp cứu https://news.medxy.ai/enhancing-suicide-prevention-teen-and-caregiver-views-on-lethal-means-safety-planning-in-the-emergency-department/Medxy AIen2026-07-14T09:19:45-07:00Enhancing Suicide Prevention: Teen and Caregiver Views on Lethal Means Safety Planning in the Emergency Department https://news.medxy.ai/zh/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma/Medxy AIzh2026-07-14T08:28:00-07:00机械通气 ICU 患者的物理约束使用：对 14 天内谵妄与昏迷无事件生存天数的影响 https://news.medxy.ai/ja/physical-restraint-use-in-mechanically-ventilated-icu-patients-free-days-over-14-days/Medxy AIja2026-07-14T08:27:08-07:00人工呼吸管理下ICU患者における身体拘束：14日間のせん妄・昏睡のない日数への影響 https://news.medxy.ai/vi/physical-restraint-use-in-mechanically-ventilated-icu-patients/Medxy AIvi2026-07-14T08:26:46-07:00Cố định thể chất ở bệnh nhân ICU thở máy: Ảnh hưởng lên sảng và số ngày không hôn mê trong 14 ngày https://news.medxy.ai/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma-free-days-over-14-days/Medxy AIen2026-07-14T08:25:04-07:00Physical Restraint Use in Mechanically Ventilated ICU Patients: Impact on Delirium and Coma-Free Days Over 14 Days https://news.medxy.ai/vi/prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients/Medxy AIvi2026-07-13T14:57:55-07:00Đánh giá sớm có hỗ trợ phần mềm giúp nâng cao khả năng dự đoán sống còn ở bệnh nhân bệnh ghép chống chủ mạn tính mới chẩn đoán https://news.medxy.ai/early-software-assisted-evaluation-enhances-prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients/Medxy AIen2026-07-13T14:57:17-07:00Early Software-Assisted Evaluation Enhances Prediction of Survival in Newly Diagnosed Chronic Graft-versus-Host Disease Patients